Soheil Ebrahimpour

ORCID: 0000-0003-3204-0448
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Brucella: diagnosis, epidemiology, treatment
  • Viral Infections and Vectors
  • Burkholderia infections and melioidosis
  • Diabetic Foot Ulcer Assessment and Management
  • Dermatological and COVID-19 studies
  • Leptospirosis research and findings
  • Infectious Diseases and Tuberculosis
  • Wound Healing and Treatments
  • Helicobacter pylori-related gastroenterology studies
  • Influenza Virus Research Studies
  • Peripheral Artery Disease Management
  • Peripheral Neuropathies and Disorders
  • Hepatitis B Virus Studies
  • Respiratory viral infections research
  • Hepatitis Viruses Studies and Epidemiology
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Animal Diversity and Health Studies
  • Viral gastroenteritis research and epidemiology
  • Global Health Care Issues
  • COVID-19 and Mental Health
  • Infectious Encephalopathies and Encephalitis
  • Health disparities and outcomes

Babol University of Medical Sciences
2016-2025

Shahid Beheshti University of Medical Sciences
2023

Imam Reza Hospital
2021-2022

Kermanshah University of Medical Sciences
2021-2022

Tehran University of Medical Sciences
2022

Islamic Azad University Rasht Branch
2020

Institute for Health Metrics and Evaluation
2018

University of Washington
2018

Tabriz University of Medical Sciences
2000

Abstract Background. In December 2019, China has experienced an outbreak of novel coronavirus disease 2019 (COVID-19). Coronavirus now spread to all the continents. We aimed consider clinical characteristics, laboratory data COVID-19 that provided more information for research this virus. Methods. performed a retrospective cohort study on symptoms and findings series 100 confirmed patients with COVID-19. These were admitted hospitals affiliated Babol University Medical Sciences (Ayatollah...

10.2478/rjim-2020-0013 article EN cc-by-nc-nd Romanian Journal of Internal Medicine 2020-05-26

While some biomolecules have been explored to identify potential biomarkers for the prognosis of COVID-19 patients, there is no reliable prognostic indicator disease progression and severity. We aimed evaluate ability C-reactive protein (CRP) predict infection outcome. This retrospective study was conducted on 429 patients diagnosed with between March 30, 2020, April 2020. The population divided into severe (n = 175) nonsevere cases 254). Data demographic characteristics, clinical features,...

10.1155/2021/5557582 article EN cc-by Interdisciplinary Perspectives on Infectious Diseases 2021-04-29

Abstract Background We aimed to prospectively assess the lung fibrotic-like changes, as well explore their predictive factors, in patients who survived Coronavirus Disease 2019 (COVID-19) infection. In this prospective cross-sectional study, we recruited had been treated for moderate or severe COVID-19 pneumonia inpatients and discharged from Rohani hospital Babol, northern Iran, during March 2020. The clinical severity of was classified per definition by World Health Organization. also...

10.1186/s43055-021-00632-9 article EN cc-by The Egyptian Journal of Radiology and Nuclear Medicine 2021-10-05

Coronavirus disease 2019 (COVID-19) vaccines significantly impacted world health and well-being. However, various adverse events have been observed following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Cutaneous reactions prevalent many vaccines, including COVID-19 vaccines. Here, we present a case of new-onset lichen planus in patient who received the vaccine at same time as being infected with SARS-CoV-2. A 52-year-old woman presented to clinic extensive...

10.1002/ccr3.5323 article EN cc-by Clinical Case Reports 2022-02-01
Ehsan Mostafavi Sana Eybpoosh Mohammad Karamouzian Malahat Khalili Saiedeh Haji‐Maghsoudi and 95 more Mostafa Salehi‐Vaziri Ali Khamesipour Tahmineh Jalali Mehran Nakhaeizadeh Hamid Sharifi Yasaman Mansoori Fariba Keramat Samad Ghodrati Mostafa Javanian Delaram Doroud Mir Davood Omrani Hassan Asadi Mohammad Hassan Pouriayevali Roya Ghasemian Hossein Farshidi Morteza Pourahmad Iman Ghasemzadeh Leila Mounesan Maryam Darvishian Mohamad Reza Mirjalili María Eugenia Toledo-Romaní Carmen Valenzuela‐Silva Vicente Vérez-Bencomo Mohammad Mehdí Gouya Hamid Emadi-Koochak Ali Akbar Haghdoost Alireza Biglari Behnaz Soleimani Tappeh Sari Soheil Ebrahimpour Rostam Heydar Tabar Roghayye Vaseghi Bahram Mirzaei Mehdi Safarpour Farzin Sadeghi Mahmoud Hosseinpoor Tayebeh Raznahan Leila Haddadi Arezoo Mobarak Abadi Elham Khalili Mehrsa Manaei Hassan Morshedi Hamed Gooklani Manoochehr Karami Mohammad Khazaei Seyyed Jalaleddin Bathaei Ali Ataei Ali Zahiri Zahra Eskandari Firouzeh Karbalaei Zadeh Elham Abdoli Marzieh Arjmandian Maryam Zamanian Razieh Sadat Mirmoeini Seyyede Zeinab Hashemi Farid Azizi Jalilian Kamal Heidari Mehdi Farsi Mahnaz Mostajeran Marjan Mashkooti Somayye Davashi Nastaran Kian Poor Asefeh Haddadpour Fariba Mazrooei Hossein Safizadeh Mohammad Reza Naghavi Saeed Sohbati Nadia Mohit Kermani Nasim Nasiri Moghaddam Shahriar Dabiri Ghasem Oveis Mohammadreza Parsaei Maghsood Khalizadeh Abbas Arjmand Fatemeh Yazdi Zadeh Hadi Dehbashi araghdari Zainab Bandalizadeh Mohammadreza Dehghani Mehrdad Mansouri Masoud Sharifi Hossein Shojaei Far Javad Soheili Sina Owlia Masoumeh Mazidi Mohammad Sharif Yazdi Mahdieh Bahri Razieh Sadat Hashemi Alireza Talebi Saeideh Anvari Ahmad Jonidi Jafari Mohammadreza Saeini Fariba Najafi Davoud Rahmani Ali Seidy Mahshid Hajikhani Hossein Dinmohammadi

Importance The protein-based SARS-CoV-2 vaccines FINLAY-FR-2 (Soberana 02) and FINLAY-FR-1A Plus) showed good safety immunogenicity in phase 1 2 trials, but the clinical efficacy of vaccine remains unknown. Objective To evaluate a 2-dose regimen (cohort 1) 3-dose with 2) Iranian adults. Design, Setting, Participants A multicenter, randomized, double-blind, placebo-controlled, 3 trial was conducted at 6 cities cohort 2. included individuals aged 18 to 80 years without uncontrolled...

10.1001/jamanetworkopen.2023.10302 article EN cc-by-nc-nd JAMA Network Open 2023-05-03

Brucellosis is one of the important multi-organ zoonotic infectious diseases. The forms clinical course brucellosis in humans are acute, sub-acute and chronic.The present study aimed to retrospectively analyze characteristics complications human Iran.The population included 957 patients admitted diseases clinic affiliated Babol University Medical Sciences, Babol, Iran, within past two decades. Data for were obtained documented questionnaires. Patients divided into three groups according...

10.5812/jjm.33765 article EN Jundishapur Journal of Microbiology 2016-04-09

The COVID-19 pandemic significantly threatens immunocompromised patients. We aimed to investigate the clinical and paraclinical findings consequences of in kidney transplantation recipients.

10.22088/cjim.16.1.96 article EN PubMed 2025-01-01
Coming Soon ...